Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C. (Q42997337)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Eva Martínez-Bauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Manuel Romero-Gómez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ricardo Moreno-Otero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ricard Solá

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Nancy Tesei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Fernando Pons

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Xavier Forns

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

José M Sánchez-Tapias

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

72-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

14 January 2020

cites work

1 reference

Predicting clinical states in individual patients

21 January 2018

1 reference

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study

1 reference

7 January 2021

Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.

1 reference

7 January 2021

Management of hepatitis C

1 reference

7 January 2021

Diagnosis, management, and treatment of hepatitis C

1 reference

7 January 2021

Predictors of response to therapy for chronic hepatitis C.

1 reference

7 January 2021

Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

1 reference

7 January 2021

Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma

1 reference

7 January 2021

Nosocomial transmission of HCV in the liver unit of a tertiary care center.

1 reference

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

7 January 2021

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

7 January 2021

Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum

1 reference

7 January 2021

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).

1 reference

7 January 2021

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

1 reference

7 January 2021

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

7 January 2021

Sources of variability in histological scoring of chronic viral hepatitis

1 reference

7 January 2021

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

7 January 2021

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

1 reference

7 January 2021

Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.

1 reference

7 January 2021

Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16374857%20AND%20SRC:MED&resulttype=core&format=json

release_gu2fl72qp5epjl5cysmjbgun5i

14 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gu2fl72qp5epjl5cysmjbgun5i

24 November 2022

mapped directly with Wikidata item

1 reference